Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease…
Parkinson Disease Psychosis
Estimated
~$10 – $6,250
Johns Hopkins UniversityNCT05824728
Phase 4
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
It is hypothesize that patients with clinically diagnosed neurodegenerative diseases will have significantly different receptor occupancy of 5HT2A receptors co…
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Estimated
~$10 – $6,250
Vanderbilt University Medical CenterNCT05357612